US Drug Recall Register

FDA Drug Recalls

14,801 recalls, newest first

Class I · High risk Terminated

Dr. King's Lymph Detox

Reason Microbial contamination

King Bio Inc. NDC 57955-5063-2 D-0522-2019
Class II · Moderate risk Terminated

Valsartan

Reason CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

Northwind Pharmaceuticals LLC D-1098-2018
Class II · Moderate risk Terminated

Valsartan

Reason CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

Northwind Pharmaceuticals LLC D-1097-2018
Class II · Moderate risk Terminated

Valsartan HCTZ

Reason CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

Northwind Pharmaceuticals LLC D-1096-2018
Class II · Moderate risk Terminated

Valsartan

Reason CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

Northwind Pharmaceuticals LLC D-1095-2018
Class II · Moderate risk Terminated

Indomethacin Capsules

Reason Failed Tablet/Capsule Specifications: customer complaints of deformed, clumped, misshaped, melted or stuck together capsules.

Hetero Labs, Ltd. - Unit III NDC 31722-543-01 D-1019-2018
Class II · Moderate risk Terminated

Potassium Citrate Extended-Release Tablets

Reason Failed Tablet/Capsule Specifications: Tablet breakage

Vensun Pharmaceuticals INC NDC 42543-407-01 D-1018-2018
Class II · Moderate risk Terminated

Potassium Citrate Extended-Release Tablets

Reason Failed Tablet/Capsule Specifications: Tablet breakage

Vensun Pharmaceuticals INC NDC 42543-408-01 D-1017-2018